Innovation – Open view page

General information

Innovation ID550
Version ID420
Innovation TitleGroundnut inbred variety CG15 for cultivation in low to mid-altitudes in Malawi and Mozambique
Innovation description CG15 is a Spanish variety that has a yield potential of 1.8 mt/ha, with drought tolerance and resistance to early leaf spot and groundnut rosette disease. It is an early-maturing variety (90-110 days) with high protein content. The pods have a medium constriction with a small pod beak and contain two seeds per pod.
Reporting Staff James Mwololo (ICRISAT)
Year (Reporting)2020
Reporting statusApproved
Innovation TypeGenetic (variety and breeds)
Number of varieties1

Stage reached

Stage of InnovationStage 3: available/ ready for uptake
Year (Stage)2020
Stage DescriptionCG15 was released on October 21, 2020, and is currently being released from production. This new variety was also released in Mozambique, and is positioned to replace the older variety JL 24.
Has a lead organizationyes
Lead OrganizationMinistry of Agriculture Irrigation and Water Development, Department of Agricultural Research Services
Top 5 contributorsInternational Crops Research Institute for the Semi-Arid Tropics

Contributions and mapping

All partners
Main CRP CGIAR Research Program on Grain Legumes and Dryland Cereals
Flagship project FP4-Variety and Hybrid Development
Cluster FP4-3-Product testing and release
Other CRPs-Flagships-Clusters

Scope

Geographic scopeNational
Regions
CountriesMalawi,Mozambique

Targeted outcomes

Main Sub-IDO Enhanced genetic gain
Other Sub-IDO Closed yield gaps through improved agronomic and animal husbandry practices
Other Sub-IDO Reduced production risk

Evidences

EvidencesList of crop varieties and hybrids released in 2020 co-developed by ICRISAT and CRP-GLDC with partners
[https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx]

Linked Elements

Milestones6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released)
Outcome Impact Case
Policy